Amgen
Trade Amgen 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About AMGN
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.
AMGN Key Statistics
Stock Snapshot
As of today, Amgen(AMGN) shares are valued at $342.01. The company's market cap stands at 184.36B, with a P/E ratio of 24.46 and a dividend yield of 2.8%.
On 2026-04-06, Amgen(AMGN) stock moved within a range of $340.64 to $348.17. With shares now at $342.01, the stock is trading +0.4% above its intraday low and -1.8% below the session's peak.
Trading volume for Amgen(AMGN) stock has reached 1.29M, versus its average volume of 3.07M.
Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $391.29 and a low of $261.43.
Over the past 52 weeks, Amgen(AMGN) stock has traded between a high of $391.29 and a low of $261.43.
AMGN News
Leerink analyst Thomas Smith notes Viridian Therapeutics’ (VRDN) shares are under pressure following topline results from Amgen’s (AMGN) Phase 3 trial of SC Tep...
Amgen (AMGN) announced positive topline results from a Phase 3 trial of tepezza administered by subcutaneous injection via an on-body injector in participants w...
Amgen Inc (AMGN) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions...
Analyst ratings
51%
of 37 ratingsMore AMGN News
Amgen Inc (AMGN) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions...
Zai Lab announced in the past that it will collaborate with Amgen on a global Phase 1b trial combining Zai Lab’s DLL3-targeting ADC zocilurtatug pelitecan with...
(RTTNews) - Shares of Zai Lab Limited (ZLAB) are moving up about 8 percent on Wednesday morning trading after the company announced a global clinical trial coll...
The FDA had asked Amgen to pull Tavneos from the U.S. market in January, citing some methodological concerns about a previous clinical trial and the risk of hep...
Teva Pharmaceutical Industries (NYSE:TEVA) received FDA approval for PONLIMSI, its denosumab biosimilar to Prolia. The company has also submitted regulatory ap...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.